Jabez Biosciences, Inc. — Form D
Jabez Biosciences, Inc. of CRANBERRY TWP., PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-21. The offering totals $3.0M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-10-21
- Form: D
- Accession: 0001213900-25-100637
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.3M
- Remaining: $1.7M
- Minimum investment: $500
- Investors: 18
- Date of first sale: 2024-08-07
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-561483
Issuer
- Name: Jabez Biosciences, Inc.
- CIK: 0002038185
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Incorporated: 2024
- Address: 2009 MACKENZIE, CRANBERRY TWP., PA, 16066
- Phone: 888-645-3947
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Robert Lewis | Director | Madison, MS |
| Robert Lewis | Executive Officer | Madison, MS |
| Robert Lewis | Promoter | Madison, MS |
| Brian Cogley | Director | Cranberry Twp, PA |
| Brian Cogley | Executive Officer | Cranberry Twp, PA |
| Michael Lewis | Promoter | Boulder, CO |
| David Mehalick | Promoter | Naples, FL |
| Bruce Cassidy | Director | Sarasota, FL |
| Tamara Jovonovich | Director | Zionsville, IN |
| Tamara Jovonovich | Executive Officer | Zionsville, IN |
| Tamara Jovonovich | Promoter | Zionsville, IN |
| Martin Lewis | Director | Plainview, TX |
Other filings by this issuer (3)
More